SUVEN PHARMACEUTICALS
Back to Cashflow Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-14 Cr | ₹-242 Cr | ₹-156 Cr | ₹-76 Cr | ₹7.32 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUVEN PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-14 Cr |
Mar2023 | ₹-242 Cr |
Mar2022 | ₹-156 Cr |
Mar2021 | ₹-76 Cr |
Mar2020 | ₹7.32 Cr |
How is Cash Flow from Financing Activities of SUVEN PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-14 Cr | Negative | |
Mar2023 | ₹-242 Cr | Negative | |
Mar2022 | ₹-156 Cr | Negative | |
Mar2021 | ₹-76 Cr | Negative | |
Mar2020 | ₹7.32 Cr | - |
Compare Cash Flow from Financing Activities of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹41,820.1 Cr | 7% | 8.6% | 26.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,667.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,131.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,745.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,603.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,429.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 7% |
8.6% |
26.2% |
SENSEX | -1.1% |
0.8% |
2.2% |
You may also like the below Video Courses